知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

28 条记录 (耗时 0.02 秒)

    TELLURIUM-CONTAINING COMPOUNDS FOR AFFECTING MALE'S FERTILITY FOLLOWING CHEMOTHERAPY AND/OR RADIOTHERAPY
    2.
    发明申请
    TELLURIUM-CONTAINING COMPOUNDS FOR AFFECTING MALE'S FERTILITY FOLLOWING CHEMOTHERAPY AND/OR RADIOTHERAPY 审中-公开
    对含有化学疗法和/或放射治疗的男性肥胖影响的含有微量元素的化合物

    公开(公告)号：US20110275709A1

    公开(公告)日：2011-11-10

    申请号：US13143546

    申请日：2010-01-07

    申请人： Benjamin Sredni ,  Michael Albeck ,  Benjamin Ron

    发明人： Benjamin Sredni ,  Michael Albeck ,  Benjamin Ron

    IPC分类号： A61K31/33 ,  A61P15/08 ,  A61P15/00 ,  C07D517/22 ,  C07D329/00

    CPC分类号： A61K45/06 ,  A61K31/095 ,  A61K33/04 ,  A61K2300/00

    摘要： Use of tellurium-containing compounds for maintaining and/or augmenting fertility in a male subject following chemotherapy and/or radiotherapy is disclosed. The tellurium-containing compound is utilized in combination with a chemotherapeutic agent and/or radiation, such that the male subject treated by the chemotherapeutic agent and/or radiation and by the tellurium-containing compound is instructed to refrain from conceptive sex for a pre-determined time period, following the chemotherapy and/or radiotherapy, during which conception is undesired.

    摘要翻译： 公开了在化学疗法和/或放射治疗之后使用含碲化合物维持和/或增加男性受试者的生育力。 使含碲化合物与化学治疗剂和/或辐射组合使用，使得由化学治疗剂和/或辐射处理的男性受试者和含碲化合物的男性受试者被指示避免概念性别， 在化学疗法和/或放射治疗之后的确定的时间段期间，不期望的概念。

    BIOLOGICALLY ACTIVE COMPLEX
    3.
    发明申请
    BIOLOGICALLY ACTIVE COMPLEX 有权
    生物活性复合物

    公开(公告)号：US20100087521A1

    公开(公告)日：2010-04-08

    申请号：US12631922

    申请日：2009-12-07

    申请人： Michael ALBECK ,  Benjamin Sredni

    发明人： Michael ALBECK ,  Benjamin Sredni

    IPC分类号： A61K31/28 ,  A61P35/00 ,  A61P25/00 ,  A61P37/00

    CPC分类号： A61K31/28 ,  C07F11/005 ,  Y02A50/393

    摘要： The invention relates to an aqueous solution containing at least one species selected from the group consisting of a 1:1 molar complex of TeO2 with a moiety of formula (A) and ammonium salts thereof: HO—X—OH   (A) where X is an optionally substituted divalent saturated hydrocarbon group containing 2-8 carbon atoms in the chain connecting the two OH groups; and its use for stimulating cells to produce cytokines and for treating mammalian diseases and conditions responsive to increased production of cytokines The complex may be used also for treating mammalian cancer which is not responsive to increased production of cytokines

    摘要翻译： 本发明涉及含有至少一种选自由TeO与式（A）部分组成的摩尔配合物及其铵盐的HO-X-OH（A）的水溶液，其中X为 在连接两个OH基团的链中含有2-8个碳原子的任选取代的二价饱和烃基; 以及其用于刺激细胞产生细胞因子和用于治疗哺乳动物疾病和对细胞因子产生增加有反应的病症的用途。该复合物还可用于治疗对细胞因子增加产生无反应的哺乳动物癌症

    Use of Tellurium Compounds for Protection from Ultra-Violet Radiation
    4.
    发明申请
    Use of Tellurium Compounds for Protection from Ultra-Violet Radiation 失效
    使用碲化合物防止紫外线辐射

    公开(公告)号：US20090269289A1

    公开(公告)日：2009-10-29

    申请号：US11992094

    申请日：2006-09-14

    申请人： Benjamin Sredni ,  Michael Albeck

    发明人： Benjamin Sredni ,  Michael Albeck

    IPC分类号： A61K8/58 ,  A61P35/00 ,  A61Q17/04

    CPC分类号： A61K31/33

    摘要： Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided.

    摘要翻译： 提供了治疗皮肤病症如基底细胞癌和/或光化性角化病的方法，其通过施用药学有效量的含碲化合物来实现。 还提供了用于治疗皮肤病症如基底细胞癌或光化性角化病的药物组合物。

    USE OF TELLURIUM COMPOUNDS FOR THE TREATMENT ACTINIC KERATOSIS
    5.
    发明申请
    USE OF TELLURIUM COMPOUNDS FOR THE TREATMENT ACTINIC KERATOSIS 审中-公开
    用于治疗药物治疗的稀土化合物的使用

    公开(公告)号：US20150023914A1

    公开(公告)日：2015-01-22

    申请号：US14257577

    申请日：2014-04-21

    申请人： BioMAS Ltd.

    发明人： Benjamin SREDNI ,  Michael ALBECK

    IPC分类号： C07F11/00 ,  A61K31/555 ,  A61K45/06

    CPC分类号： C07F11/005 ,  A61K31/395 ,  A61K31/555 ,  A61K45/06

    摘要： Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma and/or actinic keratosis is also provided.

    摘要翻译： 提供了治疗皮肤病症如基底细胞癌和/或光化性角化病的方法，其通过施用药学有效量的含碲化合物来实现。 还提供了用于治疗皮肤病症如基底细胞癌和/或光化性角化病的药物组合物。

    TELLURIUM-CONTAINING COMPOUNDS FOR AFFECTING FEMALE'S REPRODUCTIVE SYSTEM FOLLOWING CHEMOTHERAPY AND/OR RADIOTHERAPY
    9.
    发明申请
    TELLURIUM-CONTAINING COMPOUNDS FOR AFFECTING FEMALE'S REPRODUCTIVE SYSTEM FOLLOWING CHEMOTHERAPY AND/OR RADIOTHERAPY 审中-公开
    用于影响化疗和/或放射治疗的女性生殖系统的含有微量元素的化合物

    公开(公告)号：US20120035260A1

    公开(公告)日：2012-02-09

    申请号：US13143544

    申请日：2010-01-07

    申请人： Benjamin Sredni ,  Dror Meirow ,  Michael Albeck ,  Benjamin Ron

    发明人： Benjamin Sredni ,  Dror Meirow ,  Michael Albeck ,  Benjamin Ron

    IPC分类号： A61K31/21 ,  A61P15/18 ,  C07C69/74

    CPC分类号： A61K31/095 ,  A61K33/04 ,  A61K41/00 ,  A61K2300/00

    摘要： Use of tellurium-containing compounds in a method of conception and/or for maintaining and/or augmenting fertility in female following chemotherapy and/or radiotherapy is disclosed. The tellurium-containing compound is utilized in combination with a chemotherapeutic agent and/or radiation, such that the female treated by the chemotherapeutic agent and/or radiation and by the tellurium-containing compound is instructed to refrain from conceptive sex for a pre-determined time period, following the chemotherapy and/or radiotherapy, during which conception is undesired. The tellurium-containing compound is utilized in combination with a chemotherapeutic agent and/or radiation, such that the female treated by the chemotherapeutic agent and/or radiation and by the tellurium-containing compound is instructed to refrain from sex and/or from reproduction for a pre-determined time period, and is then allowed to practice reproduction.

    摘要翻译： 公开了在化学疗法和/或放射疗法中使用含碲化合物在受孕和/或维持和/或增加女性生育能力的方法中。 使含碲化合物与化学治疗剂和/或辐射组合使用，使得由化学治疗剂和/或辐射处理的女性和由含碲化合物治疗的女性被指示避免概念性的预先确定 在化疗和/或放射治疗之后的时间期间，在此期间不理想。 使含碲化合物与化学治疗剂和/或辐射组合使用，使得由化学治疗剂和/或辐射和含碲化合物治疗的雌性被指示避免性别和/或繁殖 一个预定的时间段，然后被允许练习再现。

    Biologically active complex
    10.
    发明授权
    Biologically active complex 有权
    生物活性复合物

    公开(公告)号：US08048915B2

    公开(公告)日：2011-11-01

    申请号：US12631922

    申请日：2009-12-07

    申请人： Michael Albeck ,  Benjamin Sredni

    发明人： Michael Albeck ,  Benjamin Sredni

    IPC分类号： A61K31/28

    CPC分类号： A61K31/28 ,  C07F11/005 ,  Y02A50/393

    摘要： The invention relates to an aqueous solution containing at least one species selected from the group consisting of a 1:1 molar complex of TeO2 with a moiety of formula (A) and ammonium salts thereof: HO—X—OH   (A) where X is an optionally substituted divalent saturated hydrocarbon group containing 2-8 carbon atoms in the chain connecting the two OH groups; and its use for stimulating cells to produce cytokines and for treating mammalian diseases and conditions responsive to increased production of cytokines. The complex may be used also for treating mammalian cancer which is not responsive to increased production of cytokines.

    摘要翻译： 本发明涉及含有至少一种选自由TeO与式（A）部分组成的摩尔配合物及其铵盐的HO-X-OH（A）的水溶液，其中X为 在连接两个OH基团的链中含有2-8个碳原子的任选取代的二价饱和烃基; 以及其用于刺激细胞产生细胞因子和用于治疗哺乳动物疾病和病症以对细胞因子产生增加有反应的用途。 该复合物也可用于治疗对增加的细胞因子产生无反应的哺乳动物癌症。